Miho Suzuki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Miho Suzuki has a total of 106 co-authors. Here are the top co-authors by number of shared publications:
- Keiko Shinjo
Division of Cancer Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan
5 shared publications - Yutaka Kondo
Division of Cancer Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan
5 shared publications - Yoshiteru Murofushi
Division of Cancer Biology, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan
3 shared publications - Hiroaki Kajiyama
Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Japan
2 shared publications - Kazunori Kataoka
Innovation Center of NanoMedicine (iCONM), Kawasaki Institute of Industrial Promotion, 3-25-14 Tonomachi, Kawasaki-ku, Kawasaki 210-0821, Japan
2 shared publications - Kenta Iijima
Division of Cancer Biology Nagoya University Graduate School of Medicine Nagoya Aichi Japan
2 shared publications
Latest Publications
- Open Access
- 24 November 2025
- Published by Wiley in Cancer Science
- Vol. 117 (2) , 297-307
Regulation of R‐Loop Dynamics by Proteins and Long Noncoding RNAs : An Emerging Paradigm for Cancer Treatment
R‐loops are three‐stranded nucleic acid structures comprising an RNA/DNA hybrid and a displaced single‐stranded DNA. While transient R‐loop formation is essential for various physiological processes, their persistent accumulation leads to genomic instability. Cancer cells exhibit elevated R‐loop levels due to hypertranscription, replication stress, and impaired DNA repair pathways. In this review, we provide a comprehensive overview of the molecular machinery that resolves R‐loops, including chromatin remodelers, transcriptional regulators, nucleases, and helicases. We also highlight the emerging roles of long noncoding RNAs (lncRNAs) in modulating R‐loop dynamics and explore how these RNA‐based mechanisms cooperate with canonical resolution pathways. Finally, we explore the potential of targeting R‐loop regulatory networks as a novel therapeutic strategy in cancer treatment.
- 24 November 2025
- Published by Wiley in Cancer Science
- Vol. 117 (2) , 297-307
Open AccessRegulation of R‐Loop Dynamics by Proteins and Long Noncoding RNAs : An Emerging Paradigm for Cancer Treatment
R‐loops are three‐stranded nucleic acid structures comprising an RNA/DNA hybrid and a displaced single‐stranded DNA. While transient R‐loop formation is essential for various physiological processes, their persistent accumulation leads to genomic instability. Cancer cells exhibit elevated R‐loop levels due to hypertranscription, replication stress, and impaired DNA repair pathways. In this review, we provide a comprehensive overview of the molecular machinery that resolves R‐loops, including chromatin remodelers, transcriptional regulators, nucleases, and helicases. We also highlight the emerging roles of long noncoding RNAs (lncRNAs) in modulating R‐loop dynamics and explore how these RNA‐based mechanisms cooperate with canonical resolution pathways. Finally, we explore the potential of targeting R‐loop regulatory networks as a novel therapeutic strategy in cancer treatment.
- Open Access
- 5 November 2024
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 31 (12) , 1884-1894
Novel pharmacologic inhibition of lysine-specific demethylase 1 as a potential therapeutic for glioblastoma
Lysine-specific demethylase 1 (LSD1/KDM1A) is a pivotal epigenetic enzyme that contributes to several malignancies including malignant glioma. LSD1 is a flavin adenine dinucleotide dependent histone demethylase that specifically targets histone H3 lysine (K) 4 mono- (me1) and di-methylation (me2) and H3K9me1/2 for demethylation. Herein we report the development of an LSD inhibitor, S2172, which efficiently penetrates the blood-brain barrier. S2172 effectively suppresses LSD1 enzymatic activity, resulting in the depletion of cell growth both in vitro in glioma stem cells (GSCs) (mean half-maximal inhibitory concentration (IC50) of 13.8 μM) and in vivo in a GSC orthotopic xenograft mouse model. Treatment with S2172 robustly reduced the expression of the stemness-related genes MYC and Nestin in GSC cells. Consistent with this, chromatin immunoprecipitation-sequencing revealed a significant S2172-dependent alteration in H3K4me2/H3K4me3 status. Furthermore, we identified 284 newly acquired H3K4me2 peak regions after S2172 treatment, which were encompassed within super-enhancer regions. The altered H3K4me2/H3K4me3 status induced by S2172 treatment affected the expression of genes related to tumorigenesis. Our data suggest that targeting LSD1 with S2172 could provide a promising treatment option for glioblastomas, particularly due to targeting of GSC populations.
- 5 November 2024
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 31 (12) , 1884-1894
Open AccessNovel pharmacologic inhibition of lysine-specific demethylase 1 as a potential therapeutic for glioblastoma
Lysine-specific demethylase 1 (LSD1/KDM1A) is a pivotal epigenetic enzyme that contributes to several malignancies including malignant glioma. LSD1 is a flavin adenine dinucleotide dependent histone demethylase that specifically targets histone H3 lysine (K) 4 mono- (me1) and di-methylation (me2) and H3K9me1/2 for demethylation. Herein we report the development of an LSD inhibitor, S2172, which efficiently penetrates the blood-brain barrier. S2172 effectively suppresses LSD1 enzymatic activity, resulting in the depletion of cell growth both in vitro in glioma stem cells (GSCs) (mean half-maximal inhibitory concentration (IC50) of 13.8 μM) and in vivo in a GSC orthotopic xenograft mouse model. Treatment with S2172 robustly reduced the expression of the stemness-related genes MYC and Nestin in GSC cells. Consistent with this, chromatin immunoprecipitation-sequencing revealed a significant S2172-dependent alteration in H3K4me2/H3K4me3 status. Furthermore, we identified 284 newly acquired H3K4me2 peak regions after S2172 treatment, which were encompassed within super-enhancer regions. The altered H3K4me2/H3K4me3 status induced by S2172 treatment affected the expression of genes related to tumorigenesis. Our data suggest that targeting LSD1 with S2172 could provide a promising treatment option for glioblastomas, particularly due to targeting of GSC populations.
- Open Access
- 1 April 2024
- Published by Wiley in Cancer Science
- Vol. 115 (6) , 1910-1923
Long noncoding RNATUG1 promotes cisplatin resistance in ovarian cancer via upregulation of DNA polymerase eta
Chemoresistance is a major cause of high mortality and poor survival in patients with ovarian cancer (OVCA). Understanding the mechanisms of chemoresistance is urgently required to develop effective therapeutic approaches to OVCA. Here, we show that expression of the long noncoding RNA, taurine upregulated gene 1 (TUG1), is markedly upregulated in samples from OVCA patients who developed resistance to primary platinum‐based therapy. Depletion of TUG1 increased sensitivity to cisplatin in the OVCA cell lines, SKOV3 and KURAMOCHI. Combination therapy of cisplatin with antisense oligonucleotides targeting TUG1 coupled with a drug delivery system effectively relieved the tumor burden in xenograft mouse models. Mechanistically, TUG1 acts as a competing endogenous RNA by downregulating miR‐4687‐3p and miR‐6088, both of which target DNA polymerase eta (POLH), an enzyme required for translesion DNA synthesis. Overexpression of POLH reversed the effect of TUG1 depletion on cisplatin‐induced cytotoxicity. Our data suggest that TUG1 upregulation allows OVCA to tolerate DNA damage via upregulation of POLH; this provides a strong rationale for targeting TUG1 to overcome cisplatin resistance in OVCA.
- 1 April 2024
- Published by Wiley in Cancer Science
- Vol. 115 (6) , 1910-1923
Open AccessLong noncoding RNATUG1 promotes cisplatin resistance in ovarian cancer via upregulation of DNA polymerase eta
Chemoresistance is a major cause of high mortality and poor survival in patients with ovarian cancer (OVCA). Understanding the mechanisms of chemoresistance is urgently required to develop effective therapeutic approaches to OVCA. Here, we show that expression of the long noncoding RNA, taurine upregulated gene 1 (TUG1), is markedly upregulated in samples from OVCA patients who developed resistance to primary platinum‐based therapy. Depletion of TUG1 increased sensitivity to cisplatin in the OVCA cell lines, SKOV3 and KURAMOCHI. Combination therapy of cisplatin with antisense oligonucleotides targeting TUG1 coupled with a drug delivery system effectively relieved the tumor burden in xenograft mouse models. Mechanistically, TUG1 acts as a competing endogenous RNA by downregulating miR‐4687‐3p and miR‐6088, both of which target DNA polymerase eta (POLH), an enzyme required for translesion DNA synthesis. Overexpression of POLH reversed the effect of TUG1 depletion on cisplatin‐induced cytotoxicity. Our data suggest that TUG1 upregulation allows OVCA to tolerate DNA damage via upregulation of POLH; this provides a strong rationale for targeting TUG1 to overcome cisplatin resistance in OVCA.
- Open Access
- 22 August 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-20
TUG1-mediated R-loop resolution at microsatellite loci as a prerequisite for cancer cell proliferation
Oncogene-induced DNA replication stress (RS) and consequent pathogenic R-loop formation are known to impede S phase progression. Nonetheless, cancer cells continuously proliferate under such high-stressed conditions through incompletely understood mechanisms. Here, we report taurine upregulated gene 1 (TUG1) long noncoding RNA (lncRNA), which is highly expressed in many types of cancers, as an important regulator of intrinsic R-loop in cancer cells. Under RS conditions, TUG1 is rapidly upregulated via activation of the ATR-CHK1 signaling pathway, interacts with RPA and DHX9, and engages in resolving R-loops at certain loci, particularly at the CA repeat microsatellite loci. Depletion of TUG1 leads to overabundant R-loops and enhanced RS, leading to substantial inhibition of tumor growth. Our data reveal a role of TUG1 as molecule important for resolving R-loop accumulation in cancer cells and suggest targeting TUG1 as a potent therapeutic approach for cancer treatment.
- 22 August 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-20
Open AccessTUG1-mediated R-loop resolution at microsatellite loci as a prerequisite for cancer cell proliferation
Oncogene-induced DNA replication stress (RS) and consequent pathogenic R-loop formation are known to impede S phase progression. Nonetheless, cancer cells continuously proliferate under such high-stressed conditions through incompletely understood mechanisms. Here, we report taurine upregulated gene 1 (TUG1) long noncoding RNA (lncRNA), which is highly expressed in many types of cancers, as an important regulator of intrinsic R-loop in cancer cells. Under RS conditions, TUG1 is rapidly upregulated via activation of the ATR-CHK1 signaling pathway, interacts with RPA and DHX9, and engages in resolving R-loops at certain loci, particularly at the CA repeat microsatellite loci. Depletion of TUG1 leads to overabundant R-loops and enhanced RS, leading to substantial inhibition of tumor growth. Our data reveal a role of TUG1 as molecule important for resolving R-loop accumulation in cancer cells and suggest targeting TUG1 as a potent therapeutic approach for cancer treatment.
- Top Cited Papers
- 14 June 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 15 (700) , eadd1531
Fusobacterium infection facilitates the development of endometriosis through the phenotypic transition of endometrial fibroblasts
Retrograde menstruation is a widely accepted cause of endometriosis. However, not all women who experience retrograde menstruation develop endometriosis, and the mechanisms underlying these observations are not yet understood. Here, we demonstrated a pathogenic role of Fusobacterium in the formation of ovarian endometriosis. In a cohort of women, 64% of patients with endometriosis but Fusobacterium infiltration in the endometrium. Immunohistochemical and biochemical analyses revealed that activated transforming growth factor–β (TGF-β) signaling resulting from Fusobacterium infection of endometrial cells led to the transition from quiescent fibroblasts to transgelin (TAGLN)–positive myofibroblasts, which gained the ability to proliferate, adhere, and migrate in vitro. Fusobacterium inoculation in a syngeneic mouse model of endometriosis resulted in a marked increase in TAGLN-positive myofibroblasts and increased number and weight of endometriotic lesions. Furthermore, antibiotic treatment largely prevented establishment of endometriosis and reduced the number and weight of established endometriotic lesions in the mouse model. Our data support a mechanism for the pathogenesis of endometriosis via Fusobacterium infection and suggest that eradication of this bacterium could be an approach to treat endometriosis.
- 14 June 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 15 (700) , eadd1531
Top Cited PapersFusobacterium infection facilitates the development of endometriosis through the phenotypic transition of endometrial fibroblasts
Retrograde menstruation is a widely accepted cause of endometriosis. However, not all women who experience retrograde menstruation develop endometriosis, and the mechanisms underlying these observations are not yet understood. Here, we demonstrated a pathogenic role of Fusobacterium in the formation of ovarian endometriosis. In a cohort of women, 64% of patients with endometriosis but Fusobacterium infiltration in the endometrium. Immunohistochemical and biochemical analyses revealed that activated transforming growth factor–β (TGF-β) signaling resulting from Fusobacterium infection of endometrial cells led to the transition from quiescent fibroblasts to transgelin (TAGLN)–positive myofibroblasts, which gained the ability to proliferate, adhere, and migrate in vitro. Fusobacterium inoculation in a syngeneic mouse model of endometriosis resulted in a marked increase in TAGLN-positive myofibroblasts and increased number and weight of endometriotic lesions. Furthermore, antibiotic treatment largely prevented establishment of endometriosis and reduced the number and weight of established endometriotic lesions in the mouse model. Our data support a mechanism for the pathogenesis of endometriosis via Fusobacterium infection and suggest that eradication of this bacterium could be an approach to treat endometriosis.
- Open Access
- 11 January 2021
- Published by American Physical Society (APS) in Physical Review E
- Vol. 103 (1) , 012404
Structural dynamics of DNA depending on methylation pattern
DNA methylation is associated with a number of biological phenomena, and plays crucial roles in epigenetic regulation of eukaryotic gene expression. It is also suggested that DNA methylation alters the mechanical properties of DNA molecules, which is likely to affect epigenetic regulation. However, it has not been systematically investigated how methylation changes the structural and dynamic features of DNA. In this research, to elucidate the effects of methylation on DNA mechanics, a fully atomic molecular dynamics simulation of double-stranded DNA with several methylation patterns was performed. Through the analysis of the relative positioning of the nucleotides (base-step variables), characteristic changes in terms of local flexibility were observed, which further affected the overall DNA geometry and stiffness. These findings may serve as a basis for a discussion on methylation-dependent DNA dynamics in physiological conditions.
- 11 January 2021
- Published by American Physical Society (APS) in Physical Review E
- Vol. 103 (1) , 012404
Open AccessStructural dynamics of DNA depending on methylation pattern
DNA methylation is associated with a number of biological phenomena, and plays crucial roles in epigenetic regulation of eukaryotic gene expression. It is also suggested that DNA methylation alters the mechanical properties of DNA molecules, which is likely to affect epigenetic regulation. However, it has not been systematically investigated how methylation changes the structural and dynamic features of DNA. In this research, to elucidate the effects of methylation on DNA mechanics, a fully atomic molecular dynamics simulation of double-stranded DNA with several methylation patterns was performed. Through the analysis of the relative positioning of the nucleotides (base-step variables), characteristic changes in terms of local flexibility were observed, which further affected the overall DNA geometry and stiffness. These findings may serve as a basis for a discussion on methylation-dependent DNA dynamics in physiological conditions.
- Open Access
- 6 August 2020
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Selected Topics in Quantum Electronics
- Vol. 26 (4) , C2
IEEE Journal of Selected Topics in Quantum Electronics
- 6 August 2020
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Selected Topics in Quantum Electronics
- Vol. 26 (4) , C2
Open AccessIEEE Journal of Selected Topics in Quantum Electronics
- Open Access
- 1 January 2016
- Published by Springer Nature in Analytical Sciences
- Vol. 32 (5) , 529-534
Precise Fractionation of CdSe/ZnS Quantum Dot-Organic-Dye Conjugates Using a Gel Filtration Column
Conjugates of semiconductor quantum dots (QDs) and organic dyes have been receiving attention as fluorescence biological sensing materials. In designing such sensors, a most important parameter is the number of organic-dye molecules that conjugate to a QD. If a precise separation method was developed, it might be possible to control conjugation without knowing the exact number of conjugated dye molecules per QD. In this study, the difference in linear velocities in a gel filtration column between CdSe/ZnS QDs and 5-(and 6)-carboxynaphthofluorescein succinimidyl ester is used. The velocities differ because the hydrophilicity of CdSe/ZnS QDs is much higher than that of the organic dye; hence, CdSe/ZnS-organic-dye conjugation can be controlled by changing the fraction number. Furthermore, the concentrations of CdSe/ZnS QDs and organic dye in fractionated solutions can be determined by measuring fluorescence spectra, and we demonstrate a fluorescence-type pH sensor based on the conjugate, which has a pH-sensitivity range from 7.5 - 9.5.
- 1 January 2016
- Published by Springer Nature in Analytical Sciences
- Vol. 32 (5) , 529-534
Open AccessPrecise Fractionation of CdSe/ZnS Quantum Dot-Organic-Dye Conjugates Using a Gel Filtration Column
Conjugates of semiconductor quantum dots (QDs) and organic dyes have been receiving attention as fluorescence biological sensing materials. In designing such sensors, a most important parameter is the number of organic-dye molecules that conjugate to a QD. If a precise separation method was developed, it might be possible to control conjugation without knowing the exact number of conjugated dye molecules per QD. In this study, the difference in linear velocities in a gel filtration column between CdSe/ZnS QDs and 5-(and 6)-carboxynaphthofluorescein succinimidyl ester is used. The velocities differ because the hydrophilicity of CdSe/ZnS QDs is much higher than that of the organic dye; hence, CdSe/ZnS-organic-dye conjugation can be controlled by changing the fraction number. Furthermore, the concentrations of CdSe/ZnS QDs and organic dye in fractionated solutions can be determined by measuring fluorescence spectra, and we demonstrate a fluorescence-type pH sensor based on the conjugate, which has a pH-sensitivity range from 7.5 - 9.5.
- 1 March 2011
- Published by Elsevier in Virus Research
- Vol. 156 (1-2) , 107-112
Bovine leukemia virus integration site selection in cattle that develop leukemia
- 1 March 2011
- Published by Elsevier in Virus Research
- Vol. 156 (1-2) , 107-112
Bovine leukemia virus integration site selection in cattle that develop leukemia
- Open Access
- 1 January 1992
- Published by The Chemical Society of Japan in NIPPON KAGAKU KAISHI
- No. 10,p. 1186-1188
Special Articles on Organic and Inorganic Optical Materials. Studies on Photoinduced Electrification at the Contact Interfaces. II. Photoinduced Electrification at the Contact Interface between Photopolymerizable Layer and Metal Films.
- 1 January 1992
- Published by The Chemical Society of Japan in NIPPON KAGAKU KAISHI
- No. 10,p. 1186-1188
Open AccessSpecial Articles on Organic and Inorganic Optical Materials. Studies on Photoinduced Electrification at the Contact Interfaces. II. Photoinduced Electrification at the Contact Interface between Photopolymerizable Layer and Metal Films.